Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. Hosp. Clin. Univ. Chile ; 22(2): 163-170, 2011. ilus, graf
Artículo en Español | LILACS | ID: lil-613264

RESUMEN

Currently, there is not a marker for early diagnosis of Lupus Nephropathy. TWEAK is a weak Tumor Necrosis Factor whose interaction with the receptor Fn14 in kidney tissue exerts various biological activities including events related to cell proliferation, apoptosis, angiogenesis and inflammation. Because these processes seem to be involved in the pathogenesis of Lupus Nephropathy, it has been proposed that TWEAK could be a potential therapeutic target, but also a predictor of its appearance, and then a possible marker for early diagnosis. The purpose of this article is to discuss the current state of the art in research, of this potential diagnostic tool.


Asunto(s)
Humanos , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/patología , Biomarcadores de Tumor , Factores de Necrosis Tumoral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA